L&T Technology Services Ltd’s (LTTS) shares had been up by 1.10 per cent after the corporate introduced a collaboration with NVIDIA to introduce a Gen AI and superior software-defined structure aimed toward altering medical imaging within the discipline of endoscopy. 

The software-defined structure, collectively developed by LTTS and NVIDIA, is a scalable platform serving as a decision-making software for the medical sector. Key options embody a picture processing pipeline for noise discount, edge and distinction enhancement, texture and colour enchancment, together with speckle correction. This facilitates enhanced visualisation for picture processing and AI-based decision-making help, notably in polyp detection and classification.

Shanker Trivedi, Senior Vice President of Enterprise Business at NVIDIA, said, “The combination of LTTS’ expertise in medical device development and NVIDIA’s full-stack edge AI computing platform offers value to the medical technology industry by expediting the development of AI-enabled, software-defined medical devices.”

The shares had been up by 1.10 per cent to ₹4,502.90 at 11.40 am on the BSE.